Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Keybanc raised Netflix, Inc. NFLX price target from $525 to $545. Keybanc analyst Justin Patterson maintained an Overweight rating. Netflix shares fell 2.2% to close at $481.24 on Tuesday. See how other analysts view this stock.
• Goldman Sachs increased the price target for Twist Bioscience Corporation TWST from $25 to $45. Goldman Sachs analyst Matthew Sykes upgraded the stock from Neutral to Buy. Twist Bioscience shares fell 2.4% to close at $35.27 on Tuesday. See how other analysts view this stock.
• Piper Sandler boosted the price target for Burlington Stores, Inc. BURL from $155 to $240. Piper Sandler analyst Edward Yruma upgraded the stock from Neutral to Overweight. Burlington shares rose 0.8% to close at $193.37 on Tuesday. See how other analysts view this stock.
• UBS boosted Visteon Corporation VC price target from $143 to $145. UBS analyst Joseph Spak upgraded the stock from Neutral to Buy. Visteon shares gained 1.3% to close at $115.46 on Tuesday. See how other analysts view this stock.
• JP Morgan cut the price target for Morgan Stanley MS from $94 to $87. JP Morgan analyst Kian Abouhossein downgraded the stock from Overweight to Neutral. Morgan Stanley shares fell 4.2% to close at $85.97 on Tuesday. See how other analysts view this stock.
• Rosenblatt raised the price target for ANSYS, Inc. ANSS from $332 to $345. Rosenblatt analyst Blair Abernethy downgraded the stock from Buy to Neutral. ANSYS shares fell 5.5% to close at $327.42 on Tuesday. See how other analysts view this stock.
• Barclays cut SolarEdge Technologies, Inc. SEDG price target from $74 to $50. Barclays analyst Christine Cho downgraded the stock from Equal-Weight to Underweight. SolarEdge shares fell 1.9% to close at $72.83 on Tuesday. See how other analysts view this stock.
• HC Wainwright & Co. increased Apellis Pharmaceuticals, Inc. APLS price target from $82 to $92. HC Wainwright & Co. analyst Douglas Tsao maintained a Buy rating. Apellis Pharmaceuticals shares fell 5.6% to close at $66.30 on Tuesday. See how other analysts view this stock.
• Telsey Advisory Group cut Waldencast plc WALD price target from $13 to $12. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating. Waldencast shares fell 15.3% to close at $8.70 on Tuesday. See how other analysts view this stock.
• Jefferies cut Allakos Inc. ALLK price target from $6 to $1.5. Jefferies analyst Kevin Strang downgraded the stock from Buy to Hold. Allakos shares dipped 60.2% to close at $1.19 on Tuesday. See how other analysts view this stock.

Check This Out: Top 3 Industrials Stocks That Could Blast Off In January